CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 985 of 1
Non-Antibody Products
Page 985 of 1,304
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| (±)8(9)-EET methyl ester | An esterified version of (±)8(9)-EET; more stable for long-term sto… | 50 µg | 50350-50 | More Info |
| (±)14(15)-EET-SI | A metabolically stable methyl sulfonamide analog of 14(15)-EET; equipotent… | 100 µg | 10009286-100 | More Info |
| (±)14(15)-EET-SI | A metabolically stable methyl sulfonamide analog of 14(15)-EET; equipotent… | 25 µg | 10009286-25 | More Info |
| (±)14(15)-EET-SI | A metabolically stable methyl sulfonamide analog of 14(15)-EET; equipotent… | 50 µg | 10009286-50 | More Info |
| (±)8(9)-EE-14(Z)-E | An oxylipin and a metabolite of arachidonic acid; increases glomerular mem… | 100 µg | 18112-100 | More Info |
| (±)8(9)-EE-14(Z)-E | An oxylipin and a metabolite of arachidonic acid; increases glomerular mem… | 25 µg | 18112-25 | More Info |
| (±)8(9)-EE-14(Z)-E | An oxylipin and a metabolite of arachidonic acid; increases glomerular mem… | 50 µg | 18112-50 | More Info |
| (±)8(9)-EE-14(Z)-E | An oxylipin and a metabolite of arachidonic acid; increases glomerular mem… | 500 µg | 18112-500 | More Info |
| (±)-Efavirenz-d5 | An internal standard for the quantification of efavirenz by GC- or LC-MS, | 1 mg | 25228-1 | More Info |
| (±)-Enterolactone | A phytoestrogen | 1 mg | 10112-1 | More Info |
| (±)-Enterolactone | A phytoestrogen | 10 mg | 10112-10 | More Info |
| (±)-Enterolactone | A phytoestrogen | 5 mg | 10112-5 | More Info |
| (±)-Enterolactone | A phytoestrogen | 500 µg | 10112-500 | More Info |
| (±)10(11)-EpDPA | A DHA epoxygenase metabolite detected in rat brain and spinal cord, as wel… | 100 µg | 10471-100 | More Info |
| (±)10(11)-EpDPA | A DHA epoxygenase metabolite detected in rat brain and spinal cord, as wel… | 25 µg | 10471-25 | More Info |
| (±)10(11)-EpDPA | A DHA epoxygenase metabolite detected in rat brain and spinal cord, as wel… | 50 µg | 10471-50 | More Info |
| (±)10(11)-EpDPA | A DHA epoxygenase metabolite detected in rat brain and spinal cord, as wel… | 500 µg | 10471-500 | More Info |
| (±)13(14)-EpDPA | A DHA epoxygenase metabolite found in rat brain and spinal cord that acts… | 100 µg | 10464-100 | More Info |
| (±)13(14)-EpDPA | A DHA epoxygenase metabolite found in rat brain and spinal cord that acts… | 25 µg | 10464-25 | More Info |
| (±)13(14)-EpDPA | A DHA epoxygenase metabolite found in rat brain and spinal cord that acts… | 50 µg | 10464-50 | More Info |
| (±)13(14)-EpDPA | A DHA epoxygenase metabolite found in rat brain and spinal cord that acts… | 500 µg | 10464-500 | More Info |
| (±)16(17)-EpDPA | A DHA metabolite derived via epoxidation of the 16,17-double bond; epoxyge… | 100 µg | 10174-100 | More Info |
| (±)16(17)-EpDPA | A DHA metabolite derived via epoxidation of the 16,17-double bond; epoxyge… | 25 µg | 10174-25 | More Info |
| (±)16(17)-EpDPA | A DHA metabolite derived via epoxidation of the 16,17-double bond; epoxyge… | 50 µg | 10174-50 | More Info |
| (±)16(17)-EpDPA | A DHA metabolite derived via epoxidation of the 16,17-double bond; epoxyge… | 500 µg | 10174-500 | More Info |
| (±)19(20)-EpDPA | An epoxide metabolite of DHA; formed from DHA by various CYP isoforms; sup… | 100 µg | 10175-100 | More Info |
| (±)19(20)-EpDPA | An epoxide metabolite of DHA; formed from DHA by various CYP isoforms; sup… | 25 µg | 10175-25 | More Info |
| (±)19(20)-EpDPA | An epoxide metabolite of DHA; formed from DHA by various CYP isoforms; sup… | 50 µg | 10175-50 | More Info |
| (±)19(20)-EpDPA | An epoxide metabolite of DHA; formed from DHA by various CYP isoforms; sup… | 500 µg | 10175-500 | More Info |
| (±)7(8)-EpDPA | An epoxide derivative of DHA that is generated by the action of CYP450 epo… | 100 µg | 10465-100 | More Info |
| (±)7(8)-EpDPA | An epoxide derivative of DHA that is generated by the action of CYP450 epo… | 25 µg | 10465-25 | More Info |
| (±)7(8)-EpDPA | An epoxide derivative of DHA that is generated by the action of CYP450 epo… | 50 µg | 10465-50 | More Info |
| (±)7(8)-EpDPA | An epoxide derivative of DHA that is generated by the action of CYP450 epo… | 500 µg | 10465-500 | More Info |
| (±)4(5)-EpDPA methyl ester | A stable derivative of (±)4(5)-EpDPA, a CYP450 metabolite of DHA wh… | 100 µg | 90314-100 | More Info |
| (±)4(5)-EpDPA methyl ester | A stable derivative of (±)4(5)-EpDPA, a CYP450 metabolite of DHA wh… | 25 µg | 90314-25 | More Info |
| (±)4(5)-EpDPA methyl ester | A stable derivative of (±)4(5)-EpDPA, a CYP450 metabolite of DHA wh… | 50 µg | 90314-50 | More Info |
| (±)4(5)-EpDPA methyl ester | A stable derivative of (±)4(5)-EpDPA, a CYP450 metabolite of DHA wh… | 500 µg | 90314-500 | More Info |
| (±)19(20)-EpDTE | An oxylipin; an oxidative metabolite of DPA; formed via CYP metabolism of… | 100 µg | 20331-100 | More Info |
| (±)19(20)-EpDTE | An oxylipin; an oxidative metabolite of DPA; formed via CYP metabolism of… | 25 µg | 20331-25 | More Info |
| (±)19(20)-EpDTE | An oxylipin; an oxidative metabolite of DPA; formed via CYP metabolism of… | 50 µg | 20331-50 | More Info |
| (±)7(8)-EpDTE | An oxylipin; oxidative metabolite of DPA; formed via CYP metabolism of DPA… | 100 µg | 20326-100 | More Info |
| (±)7(8)-EpDTE | An oxylipin; oxidative metabolite of DPA; formed via CYP metabolism of DPA… | 25 µg | 20326-25 | More Info |
| (±)7(8)-EpDTE | An oxylipin; oxidative metabolite of DPA; formed via CYP metabolism of DPA… | 50 µg | 20326-50 | More Info |
| (±)14(15)-EpEDE | An EpEDE acid formed from DGLA, either by a strong oxidizing agent or by c… | 100 µg | 10007527-100 | More Info |
| (±)14(15)-EpEDE | An EpEDE acid formed from DGLA, either by a strong oxidizing agent or by c… | 25 µg | 10007527-25 | More Info |
| (±)14(15)-EpEDE | An EpEDE acid formed from DGLA, either by a strong oxidizing agent or by c… | 50 µg | 10007527-50 | More Info |
| (±)14(15)-EpEDE | An EpEDE acid formed from DGLA, either by a strong oxidizing agent or by c… | 500 µg | 10007527-500 | More Info |
| (±)14(15)-EpEDE methyl ester | A lipid soluble analog of (±)14(15)-EpEDE | 100 µg | 10007528-100 | More Info |
| (±)14(15)-EpEDE methyl ester | A lipid soluble analog of (±)14(15)-EpEDE | 25 µg | 10007528-25 | More Info |
| (±)14(15)-EpEDE methyl ester | A lipid soluble analog of (±)14(15)-EpEDE | 50 µg | 10007528-50 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile